253597-19-2

Basic information

• Product Name: 5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid
• Synonyms: Cleviprex Impurity C;Clevidipine Butyrate Impurity;5-((Bis(butyryloxy)methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3;5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid;bis((butyryloxy)Methyl) 4-(2',3'-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3,5-dicarboxylate;Clevidipine Butyrate iMpurity Ⅰ;5-((Bis(butyryloxy)methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-ca;Clevidipine Butyrate Impurity E
• CAS NO: 253597-19-2
• Molecular Formula: C24H27Cl2NO8
• Molecular Weight: 528.37908
• Product Categories: Clevidipine Butyrate impurity
• Mol File: 253597-19-2.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 611.9±55.0 °C(Predicted)
• Appearance: /
• Density: 1.281±0.06 g/cm3(Predicted)
• PKA: 2.25±0.70(Predicted)
• CAS DataBase Reference: 5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: 5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid(253597-19-2)
• EPA Substance Registry System: 5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid(253597-19-2)

Safety Data

• Hazardous Substances Data: 253597-19-2(Hazardous Substances Data)

Usage

General Description

5-((Bis(butyryloxy)Methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-diMethyl-1,4-dihydropyridine-3-carboxylic acid is a chemical compound that belongs to the dihydropyridine class of calcium channel blockers. It is used in the treatment of high blood pressure, angina pectoris, and certain types of arrhythmias. The compound works by blocking the influx of calcium ions into smooth muscle and cardiac muscle cells, leading to relaxation and dilation of the blood vessels and decreased cardiac contractility and conductivity. It is important to note that this compound should only be used under the supervision of a healthcare professional, as it may have potential side effects and interactions with other medications.